HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2,2',4,4',5,5'-Hexabromophenyl ether (BDE-153) causes abnormal insulin secretion and disorders of glucose and lipid metabolism in mice.

AbstractBACKGROUND:
Environmental polybrominated diphenyl ether (PBDE) exposure may be associated with diabetes and obesity. 2,2',4,4',5,5'-Hexabromodiphenyl ether (BDE-153) is one of the most abundant and widely distributed homologs of PBDEs detected in humans. This study investigated the effects of BDE-153 on the expression of adipokines and glucose and lipid metabolism.
METHODS:
Adult male C57BL/6 mice were divided into five BDE-153 groups and one control group. After BDE-153 exposure for 4 weeks, the levels of biochemical indexes and the mRNA and protein expression levels of leptin, adiponectin, peroxisome proliferators activated receptors gamma (PPARγ), and AMPKα were measured. The histomorphological changes of liver and pancreas tissues were observed.
RESULTS:
After BDE-153 exposure, the weight of mice in the medium-high-dose group at different exposure times was lower than that in the control group ( p all <0.05), and the body weight decreased slightly with the increase of the dose of BDE-153. BDE-153 caused the disorder of glucose and lipid metabolism in mice, the weight of liver and pancreas increased, lipid droplets accumulated in liver cells, and the positive rate of insulin staining increased in a dose-dependent manner. BDE-153 also interfered with the expression of PPARγ, AMPKα, and adipokines. The results of restrictive cubic splines (RCS) showed that there were a nonlinear dose-response relationship between the exposure dose of BDE-153 and the expression levels of PPARγ, AMPKα, and adipokines.
CONCLUSION:
Our results suggest that BDE-153 may interfere with the expression of adipokines and the secretion of insulin by affecting the expression of PPARγ and AMPKα, which play a key role in glucose and lipid metabolism, leading to the occurrence of glucose and lipid metabolism disorder.
AuthorsZao-Ling Liu, Shu-Rui Jiang, Yong Fan, Jia-Sui Wang, Meng-Lin Wang, Mei-Yan Li
JournalJournal of the Chinese Medical Association : JCMA (J Chin Med Assoc) Vol. 86 Issue 4 Pg. 388-398 (04 01 2023) ISSN: 1728-7731 [Electronic] Netherlands
PMID36727784 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2023, the Chinese Medical Association.
Chemical References
  • Glucose
  • Insulin
  • hexabrominated diphenyl ether 153
  • Ether
  • PPAR gamma
  • Ethyl Ethers
  • Adipokines
  • Ethers
Topics
  • Humans
  • Adult
  • Male
  • Animals
  • Mice
  • Glucose
  • Insulin (metabolism)
  • Insulin Secretion
  • Ether
  • Lipid Metabolism
  • PPAR gamma
  • Mice, Inbred C57BL
  • Ethyl Ethers
  • Adipokines (metabolism)
  • Ethers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: